Commonwealth Equity Services LLC Takes $402,000 Position in Enovis Co. (NYSE:ENOV)

Commonwealth Equity Services LLC purchased a new position in shares of Enovis Co. (NYSE:ENOV - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 9,163 shares of the company's stock, valued at approximately $402,000.

Other institutional investors have also modified their holdings of the company. DAVENPORT & Co LLC increased its stake in Enovis by 6.0% during the 4th quarter. DAVENPORT & Co LLC now owns 2,782,341 shares of the company's stock worth $121,181,000 after buying an additional 157,216 shares during the period. State Street Corp increased its position in shares of Enovis by 4.3% during the third quarter. State Street Corp now owns 1,647,220 shares of the company's stock worth $70,913,000 after acquiring an additional 68,190 shares during the period. River Road Asset Management LLC increased its position in shares of Enovis by 3.8% during the fourth quarter. River Road Asset Management LLC now owns 1,238,357 shares of the company's stock worth $54,339,000 after acquiring an additional 45,762 shares during the period. Geode Capital Management LLC raised its stake in shares of Enovis by 9.5% in the third quarter. Geode Capital Management LLC now owns 921,437 shares of the company's stock valued at $39,678,000 after acquiring an additional 80,165 shares in the last quarter. Finally, Artemis Investment Management LLP boosted its holdings in Enovis by 35.4% in the fourth quarter. Artemis Investment Management LLP now owns 665,868 shares of the company's stock valued at $29,218,000 after purchasing an additional 174,116 shares during the period. 98.45% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Separately, Needham & Company LLC restated a "buy" rating and set a $64.00 price target on shares of Enovis in a report on Wednesday.

Enovis Stock Down 0.5 %

Shares of NYSE:ENOV traded down $0.17 during trading hours on Friday, reaching $31.93. The stock had a trading volume of 1,011,678 shares, compared to its average volume of 733,297. Enovis Co. has a 1 year low of $29.32 and a 1 year high of $59.63. The firm's 50 day moving average is $38.85 and its 200-day moving average is $42.55. The stock has a market capitalization of $1.82 billion, a price-to-earnings ratio of -14.58 and a beta of 1.86. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.12 and a current ratio of 2.27.

Enovis (NYSE:ENOV - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.98 EPS for the quarter, beating the consensus estimate of $0.92 by $0.06. The firm had revenue of $560.98 million for the quarter, compared to analyst estimates of $555.14 million. Enovis had a positive return on equity of 4.39% and a negative net margin of 5.95%. Research analysts predict that Enovis Co. will post 2.79 earnings per share for the current fiscal year.

Enovis Profile

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.